Article
Study shows reduced refractive error, improved higher-order aberrations, contrast sensitivity
Galimedix Therapeutics initiates eDREAM phase 2 clinical trial in dry age-related macular degeneration
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
2024 in the rearview: Top stories from this year in optometry
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Wrapping up another year in eye care: 2024 in review from Ophthalmology Times Europe
Playing matchmaker with Schlemm canal surgery